• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼快速进展者的短期检测:通过聚类评估进行快速进展评估(Fast-PACE)研究

Short-term Detection of Fast Progressors in Glaucoma: The Fast Progression Assessment through Clustered Evaluation (Fast-PACE) Study.

作者信息

Medeiros Felipe A, Malek Davina A, Tseng Henry, Swaminathan Swarup S, Boland Michael V, Friedman David S, Jammal Alessandro A

机构信息

Bascom Palmer Eye Institute, University of Miami, Miami, Florida; Duke Eye Center and Department of Ophthalmology, Duke University, Durham, North Carolina.

Bascom Palmer Eye Institute, University of Miami, Miami, Florida.

出版信息

Ophthalmology. 2024 Jun;131(6):645-657. doi: 10.1016/j.ophtha.2023.12.031. Epub 2023 Dec 29.

DOI:10.1016/j.ophtha.2023.12.031
PMID:38160883
Abstract

PURPOSE

To evaluate the performance of an intensive, clustered testing approach in identifying eyes with rapid glaucoma progression over 6 months in the Fast Progression Assessment through Clustered Evaluation (Fast-PACE) Study.

DESIGN

Prospective cohort study.

PARTICIPANTS

A total of 125 eyes from 65 primary open-angle glaucoma (POAG) subjects.

METHODS

Subjects underwent 2 sets of 5 weekly visits (clusters) separated by an average of 6 months and then were followed with single visits every 6 months for an overall mean follow-up of 25 months (mean of 17 tests). Each visit consisted of testing with standard automated perimetry (SAP) 24-2 and 10-2, and spectral-domain OCT (SD-OCT). Progression was assessed using trend analyses of SAP mean deviation (MD) and retinal nerve fiber layer (RNFL) thickness. Generalized estimating equations were applied to adjust for correlations between eyes for confidence interval (CI) estimation and hypothesis testing.

MAIN OUTCOME MEASURES

Diagnostic accuracy of the 6-month clustering period to identify progression detected during the overall follow-up.

RESULTS

A total of 19 of 125 eyes (15%, CI, 9%-24%) progressed based on SAP 24-2 MD over the 6-month clustering period. A total of 14 eyes (11%, CI, 6%-20%) progressed on SAP 10-2 MD, and 16 eyes (13%, CI, 8%-21%) progressed by RNFL thickness, with 30 of 125 eyes (24%, CI, 16%-34%) progressing by function, structure, or both. Of the 35 eyes progressing during the overall follow-up, 25 had progressed during the 6-month clustering period, for a sensitivity of 71% (CI, 53%-85%). Of the 90 eyes that did not progress during the overall follow-up, 85 also did not progress during the 6-month period, for a specificity of 94% (CI, 88%-98%). Of the 14 eyes considered fast progressors by SAP 24-2, SAP 10-2, or SD-OCT during the overall follow-up, 13 were identified as progressing during the 6-month cluster period, for a sensitivity of 93% (CI, 66%-100%) for identifying fast progression with a specificity of 85% (CI, 77%-90%).

CONCLUSIONS

Clustered testing in the Fast-PACE Study detected fast-progressing glaucoma eyes over 6 months. The methodology could be applied in clinical trials investigating interventions to slow glaucoma progression and may be of value for short-term assessment of high-risk subjects.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references in the Footnotes and Disclosures at the end of this article.

摘要

目的

在通过聚类评估进行快速进展评估(Fast-PACE)研究中,评估一种密集的聚类检测方法在识别6个月内青光眼快速进展眼方面的性能。

设计

前瞻性队列研究。

参与者

来自65例原发性开角型青光眼(POAG)受试者的125只眼。

方法

受试者接受2组每周5次的就诊(聚类),平均间隔6个月,然后每6个月进行单次就诊,总体平均随访25个月(平均17次检查)。每次就诊包括使用标准自动视野计(SAP)24-2和10-2以及光谱域光学相干断层扫描(SD-OCT)进行检测。使用SAP平均偏差(MD)和视网膜神经纤维层(RNFL)厚度的趋势分析来评估进展情况。应用广义估计方程来调整眼间相关性,以进行置信区间(CI)估计和假设检验。

主要观察指标

6个月聚类期识别总体随访期间检测到的进展的诊断准确性。

结果

在6个月聚类期内,基于SAP 24-2 MD,125只眼中共有19只(15%,CI,9%-24%)进展。基于SAP 10-2 MD有14只眼(11%,CI,6%-20%)进展,基于RNFL厚度有16只眼(13%,CI,8%-21%)进展,125只眼中有30只(24%,CI,16%-34%)在功能、结构或两者方面进展。在总体随访期间进展的35只眼中,25只在6个月聚类期内进展,敏感性为71%(CI,53%-85%)。在总体随访期间未进展的90只眼中,85只在6个月期间也未进展,特异性为94%(CI,88%-98%)。在总体随访期间被SAP 24-2、SAP 10-2或SD-OCT视为快速进展者的14只眼中,13只在6个月聚类期内被识别为进展,识别快速进展的敏感性为93%(CI,66%-100%),特异性为85%(CI,77%-90%)。

结论

Fast-PACE研究中的聚类检测在6个月内检测到了青光眼快速进展眼。该方法可应用于研究减缓青光眼进展干预措施的临床试验,可能对高危受试者的短期评估有价值。

财务披露

在本文末尾的脚注和披露中的参考文献之后可能会发现专有或商业披露。

相似文献

1
Short-term Detection of Fast Progressors in Glaucoma: The Fast Progression Assessment through Clustered Evaluation (Fast-PACE) Study.青光眼快速进展者的短期检测:通过聚类评估进行快速进展评估(Fast-PACE)研究
Ophthalmology. 2024 Jun;131(6):645-657. doi: 10.1016/j.ophtha.2023.12.031. Epub 2023 Dec 29.
2
Accelerated Epigenetic Aging Is Associated with Faster Glaucoma Progression: A DNA Methylation Study.加速的表观遗传衰老与青光眼进展加快相关:一项DNA甲基化研究。
Ophthalmology. 2025 May;132(5):550-560. doi: 10.1016/j.ophtha.2024.12.034. Epub 2024 Dec 21.
3
Optic nerve head and fibre layer imaging for diagnosing glaucoma.用于诊断青光眼的视神经乳头和纤维层成像。
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD008803. doi: 10.1002/14651858.CD008803.pub2.
4
Optic Disc Size and Circumpapillary Retinal Nerve Fiber Layer Thinning in Glaucoma.青光眼患者的视盘大小与视乳头周围视网膜神经纤维层变薄
Ophthalmol Glaucoma. 2025 Jul-Aug;8(4):343-350. doi: 10.1016/j.ogla.2025.02.003. Epub 2025 Feb 21.
5
Rate of Progression Among Different Age Groups in Glaucoma With High Myopia: A 10-Year Follow-Up Cohort Study.高度近视性青光眼不同年龄组的病情进展率:一项10年随访队列研究
Am J Ophthalmol. 2025 Aug;276:201-209. doi: 10.1016/j.ajo.2025.04.012. Epub 2025 Apr 18.
6
Visual Field of Eyes with Peripapillary Intrachoroidal Cavitation and Its Association with Deep Optic Nerve Head Structural Changes.伴有视乳头周围脉络膜腔隙形成的眼睛的视野及其与深部视神经乳头结构变化的关联。
Ophthalmol Glaucoma. 2025 Mar 24. doi: 10.1016/j.ogla.2025.03.007.
7
Retinal Nerve Fiber Layer Rates of Change: Comparison of 2 OCT Devices.视网膜神经纤维层变化率:两种光学相干断层扫描设备的比较
Ophthalmol Glaucoma. 2025 Jul-Aug;8(4):375-383. doi: 10.1016/j.ogla.2025.02.005. Epub 2025 Mar 4.
8
Progression or Aging? A Deep Learning Approach for Distinguishing Glaucoma Progression From Age-Related Changes in OCT Scans.进展还是衰老?一种用于区分 OCT 扫描中青光眼进展与年龄相关变化的深度学习方法。
Am J Ophthalmol. 2024 Oct;266:46-55. doi: 10.1016/j.ajo.2024.04.030. Epub 2024 May 3.
9
Peripheral iridotomy for pigmentary glaucoma.色素性青光眼的周边虹膜切开术
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD005655. doi: 10.1002/14651858.CD005655.pub2.
10
Ganglion Cell Layer Thickness as a Biomarker for Amyotrophic Lateral Sclerosis Functional Outcome: An OCT study.神经节细胞层厚度作为肌萎缩侧索硬化症功能预后的生物标志物:一项光学相干断层扫描研究。
Rom J Ophthalmol. 2025 Apr-Jun;69(2):200-207. doi: 10.22336/rjo.2025.32.

本文引用的文献

1
Validation of Rates of Mean Deviation Change as Clinically Relevant End Points for Glaucoma Progression.平均偏差变化率作为青光眼进展的临床相关终点的验证。
Ophthalmology. 2023 May;130(5):469-477. doi: 10.1016/j.ophtha.2022.12.025. Epub 2022 Dec 24.
2
Rates of Glaucoma Progression Derived from Linear Mixed Models Using Varied Random Effect Distributions.基于不同随机效应分布的线性混合模型推算的青光眼进展速率。
Transl Vis Sci Technol. 2022 Feb 1;11(2):16. doi: 10.1167/tvst.11.2.16.
3
Using the Rate of Glaucomatous Visual Field Progression in One Eye to Help Assess the Rate in the Fellow Eye.
利用一眼的青光眼视野进展率来帮助评估对侧眼的进展率。
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):360-368. doi: 10.1016/j.ogla.2020.05.006. Epub 2020 May 27.
4
Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study.从大型临床人群中观察青光眼结构和功能变化的速率:杜克青光眼登记研究。
Am J Ophthalmol. 2021 Feb;222:238-247. doi: 10.1016/j.ajo.2020.05.019. Epub 2020 May 23.
5
Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints.当使用光学相干断层扫描和视野终点联合时,青光眼临床试验的样本量要求。
Sci Rep. 2019 Dec 11;9(1):18886. doi: 10.1038/s41598-019-55345-x.
6
Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure.眼压似乎得到良好控制的眼中的角膜生物力学和视野进展。
Ophthalmology. 2019 Dec;126(12):1640-1646. doi: 10.1016/j.ophtha.2019.07.023. Epub 2019 Aug 9.
7
Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies.口服美金刚治疗青光眼:两项随机、安慰剂对照、3 期研究的设计和结果。
Ophthalmology. 2018 Dec;125(12):1874-1885. doi: 10.1016/j.ophtha.2018.06.017. Epub 2018 Aug 3.
8
Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials.不同视野测试范式对青光眼临床试验样本量需求的影响。
Sci Rep. 2018 Mar 20;8(1):4889. doi: 10.1038/s41598-018-23220-w.
9
Impact of Normal Aging and Progression Definitions on the Specificity of Detecting Retinal Nerve Fiber Layer Thinning.正常衰老和进展定义对检测视网膜神经纤维层变薄特异性的影响。
Am J Ophthalmol. 2017 Sep;181:106-113. doi: 10.1016/j.ajo.2017.06.017. Epub 2017 Jun 29.
10
Frequency of Testing to Detect Visual Field Progression Derived Using a Longitudinal Cohort of Glaucoma Patients.基于青光眼患者纵向队列检测视野进展的检测频率。
Ophthalmology. 2017 Jun;124(6):786-792. doi: 10.1016/j.ophtha.2017.01.027. Epub 2017 Mar 6.